1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,069 | 0,101 | 12:39 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | hVIVO PLC - Notice of Results | - | RNS | ||
| 26.03. | hVIVO PLC - Holding(s) in Company | 1 | RNS | ||
| 23.02. | hVIVO PLC - Issue of Equity and Total Voting Rights | - | RNS | ||
| 29.01. | hVIVO PLC - Trading Update | - | RNS | ||
| 27.01. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 18.12.25 | hVIVO PLC - Appointment of Non-Executive Director | - | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 15.12.25 | hVIVO PLC - CEO & CFO Share Purchase | - | RNS | ||
| 12.12.25 | Broker tips: Hvivo, Whitbread, IHG | 3 | Sharecast | ||
| 12.12.25 | Shore Capital hails improved US biotech funding environment for hVIVO | 1 | Sharecast | ||
| 27.11.25 | Hvivo client acquired by MSD in $9.2bn deal | 8 | Sharecast | ||
| 27.11.25 | hVIVO PLC - MSD to acquire Cidara | 24 | RNS | ||
| 20.11.25 | hVIVO PLC - >£5 million CRS contracts signed | - | RNS | ||
| 11.11.25 | hVIVO develops three new human challenge models for viral testing | 3 | Investing.com | ||
| 11.11.25 | hVIVO meldet erfolgreiche Entwicklung von drei neuen humanen Challenge-Modellen | 1 | Investing.com Deutsch | ||
| 11.11.25 | hVIVO PLC - Positive data from novel human challenge models | - | RNS | ||
| 03.11.25 | hVIVO PLC - Presentation at Jefferies Healthcare Conference | - | RNS |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,011 | -3,51 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| PLUS THERAPEUTICS | 4,750 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline | HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| UNIDOC HEALTH | 0,066 | +3,47 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,030 | -4,76 % | Mountain Valley MD Holdings Inc: Mountain Valley arranges offering, two debt settlements | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 5,469 | -1,73 % | HSI Weakens on Thinner Turnover; Auto Stocks Rally; JD Health Slumps Over 9% | ||
| LIFEWARD | 6,440 | 0,00 % | Lifeward Ltd.: Lifeward Successfully Closes on Strategic Partnership with Oramed | HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| LIGHT AI | 0,043 | -23,38 % | Light AI Inc. reports FY results | ||
| EKSO BIONICS | 9,050 | 0,00 % | EKSO BIONICS HOLDINGS, INC. - 10-K/A, Annual Report | ||
| IMUNON | 2,660 | +4,72 % | Comeback im Ländle von Ex-VP-Chef Arni: Zürcher im VR von Celsion Bank, die mit Kryptos durchstarten ... | ||
| ROCKWELL MEDICAL | 0,775 | +0,65 % | H.C. Wainwright cuts Rockwell Medical stock price target to $2 on sales miss | ||
| AROVELLA THERAPEUTICS | 0,051 | -7,27 % | AROVELLA THERAPEUTICS LIMITED: Notification of cessation of securities - ALA | ||
| MEMPHASYS | 0,002 | 0,00 % | MEMPHASYS LIMITED: Investor Presentation - April 2026 | ||
| PREVECEUTICAL MEDICAL | 0,007 | -6,67 % | PreveCeutical Medical Inc.: PreveCeutical Adopts Semi-Annual Financial Reporting | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 12,700 | -0,78 % | Why Is Viridian Therapeutics Stock Sinking Monday? |
Das Unternehmen HVIVO PLC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,081 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.